• Home
  • Contact Us
  • Try it!
  • Graphs
  • Publications
  • Blog

Follow us

Recent Posts

  • Biovista Vizit New Feature: Drug Combination Detection July 6, 2026
  • NEWROAD final meeting April 28, 2026
  • Biovista Vizit New Corpus: ClinicalTrials.gov September 16, 2025
  • Biovista Vizit New Corpus: MATISSE (a SoftMining algorithm) May 13, 2025
  • Biovista Vizit New Corpus: HPO March 4, 2025

Biovista Vizit

Biovista Vizit

  • Try it!
  • Graphs
  • Publications
  • Blog

DOPAMINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

TRACHEA TREPONEMA DENTICOLA VEGF TROPISM TROGLITAZONE VEGFA THORAX WOUND HEALING TH17 CELLS TRASTUZUMAB TAU TISSUE DEVELOPMENT TRANSLATION VEINS THY-1 ANTIGENS VITAMIN D X-RAY COMPUTED TOMOGRAPHY TIMELESS UBIQUITINATION VIRUS DISEASES ULCERATIVE COLITIS THROMBIN TECFIDERA TUMOR TYPE 2 DIABETES VASCULAR VASOCONSTRICTION TGF-BETA TARGET LESION IDENTIFICATION THROMBOCYTOPENIA TUMOR GROWTH VERO CELLS TUMOR PROGRESSION THROMBOSIS Uberon VGF PROTEIN TP53 TRANSPORT VIRAL RELEASE FROM HOST CELL VASODILATION TAUOPATHIES UCHL1 PROTEIN TMPRSS2

© 2026 Biovista Vizit All Rights Reserved.

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}